About GLP-1.COM Prices

GLP-1.COM's cash prices are based on multiple sources, including published price lists, purchases, claims records, and data provided by providers. Our discount and coupon prices are based on contracts between a provider (or provider purchasing group) and a Benefit Manager (BM), who provides prices to us.

The prices we show are our best estimate; while we believe our data to be generally accurate, we cannot guarantee that the price we display will exactly match the price you receive at the provider. For an exact price, please contact the provider.

Please keep in mind that the provider will require the information shown on GLP-1.COM coupon/discount to confirm the discount price.

Manufacturer Coupon

Many manufacturers offer programs that will reduce your out-of-pocket costs for this prescription. These programs are free but may have some rules or restrictions, so you’ll want to review carefully. When you’re ready to use this coupon, simply present the coupon to your pharmacist with a valid prescription for your medication.

Program Name:

Ozempic Savings Card

Provider:

Novo Nordisk

Phone Number:

1-877-304-6855

Website:

https://www.novocare.com/diabetes/products/ozempic/savings-offer.html

How do I get the discount?

Register online to download and print a card.

How much can I save?

Your out-of-pocket cost can be reduced to as little as $25 per 28-, 56-, or 84-day supply with a maximum savings limit of $150 per 28-day supply.

Do I need insurance?

Yes. The program is for commercially insured patients only.

Number of uses:

Up to 24 monthly uses.
No ThanksVisit Manufacturer Site

Patient Assistance Program from Novo Nordisk

Many programs are available from federal and state governments, non-profits, manufacturers, and other organizations to help you get the drugs you need at a reduced cost. Eligibility is often based on income, insurance or Medicare status, and other factors. You’ll need to apply through each program, either online, over the phone, or with your doctor's help. The following program is available for this drug.

Program Name:

Novo Nordisk Patient Assistance Program

Provider:

Novo Nordisk

Phone Number:

1-866-310-7549

Website:

https://www.novocare.com/psp/PAP.html

How do I apply?

Ask your doctor to help you fill out an application. You can find the form on the program website and can be submitted by mail or fax.

What are the benefits?

You can receive your medication at no cost.

What are the restrictions?

Most people without insurance and with limited incomes will qualify. You will need a valid prescription and proof of household income or documentation showing loss of healthcare benefits.

Keep in mind

If you have lost health insurance coverage because of a change in job status due to the COVID-19 pandemic, you may now be eligible to receive insulin free of charge for 90 days.
No ThanksLearn More

Fill a 90-Day Supply to Save

You may find that filling a 90-day supply will reduce your total cost for this prescription. As an added bonus, you'll make fewer trips to the pharmacy, saving you time and money.

If you have insurance or Medicare, you may find that you receive lower prices if you fill your prescriptions through your plan’s mail order pharmacy. Many insurance plans (and most Medicare plans) are now offering similar rates at a select group of “preferred” retail pharmacies. Some plans may require that you fill through a mail order pharmacy for fills of more than a 30-day supply.

To switch to 90-day fills, note that you'll need a new prescription from your doctor; a 30-day quantity prescription will not allow 90-day fills.
No ThanksSee 90-Day Prices

Lower Cost Alternative

There may be other prescriptions in the same class (that work in the same way) that could treat your condition just as well at a much lower cost.

If you're taking an expensive brand-name-only drug, it may be worth asking your doctor if there are any other less expensive, generic, or over-the-counter options that might work for you.
No ThanksSee Alternative Prescriptions

Retatrutide

Popular offersWays to save on RetatrutideGet answersMore articles

About Retatrutide

Retatrutide (LY3437943) is an investigational triple-hormone receptor agonist being developed by Eli Lilly for obesity and type 2 diabetes. Unlike single or dual agonists, retatrutide targets three receptors simultaneously: GIP, GLP-1, and glucagon. This triple-action mechanism works by reducing appetite, slowing gastric emptying, improving insulin secretion, and increasing energy expenditure. Retatrutide is administered as a once-weekly injection. Phase 2 clinical trials showed participants lost up to 24.2% of body weight over 48 weeks. Retatrutide is currently in Phase 3 clinical trials and is not yet FDA-approved. There are no generic alternatives for retatrutide.

Ways to save on Retatrutide

These programs and tips can help make your prescription more affordable

Patient Assistance Program from Novo Nordisk

Receive your prescription at no charge if you are eligible.

Fill a 90-Day Supply to Save

You may be able to lower your total cost by filling a greater quantity at one time.

Lower Cost Alternative

Less expensive drugs that work the same way may be available.

Common questions about Retatrutide

Is retatrutide FDA-approved?

No, retatrutide is not FDA-approved. It is currently in Phase 3 clinical trials (TRIUMPH trials) conducted by Eli Lilly. Based on current timelines, FDA approval could potentially occur in 2026 or 2027, with commercial availability following shortly after. Any products claiming to be retatrutide sold online are unapproved and potentially dangerous.

How is retatrutide different from Ozempic or Mounjaro?

Retatrutide is a "triple agonist" that activates three hormone receptors: GIP, GLP-1, and glucagon. Ozempic (semaglutide) activates only the GLP-1 receptor, while Mounjaro (tirzepatide) activates two receptors (GIP and GLP-1). The addition of glucagon receptor activation may increase energy expenditure and fat burning, potentially leading to greater weight loss.

How much weight can you lose on retatrutide?

In Phase 2 clinical trials, participants taking the highest dose (12mg) lost an average of 24.2% of their body weight over 48 weeks. The Phase 3 TRIUMPH-4 trial reported up to 28.7% weight loss at 68 weeks. These results exceed those seen with currently approved GLP-1 medications.

What are the common side effects of retatrutide?

The most frequently reported side effects in clinical trials were gastrointestinal, including nausea, diarrhea, vomiting, and constipation. These side effects were dose-dependent, occurring more frequently at higher doses, and were primarily mild to moderate in severity. Most side effects occurred during the dose escalation period and improved over time.

Can I buy retatrutide online or from a compounding pharmacy?

No. The FDA has warned against purchasing retatrutide from any source, as it is not approved for any use. Compounded versions are illegal and potentially dangerous. The only legitimate way to access retatrutide is through participation in an official Eli Lilly clinical trial.

When will retatrutide be available?

Based on current Phase 3 trial timelines, Eli Lilly could submit for FDA approval in late 2025 or early 2026. If approved, commercial availability is expected in late 2026 or early 2027. However, delays are possible depending on trial results and FDA review.

Read More

Ozempic Dose Day Strategy: What to Eat Before and After Your Injection

Ozempic dose day support: Nutrition that works

Read More

Ozempic and Low Appetite Days: How to Hit Protein and Calories Without Forcing Meals

Ozempic low appetite days: How to eat enough

Read More

Ozempic and Caffeine Sensitivity: Why Coffee Can Feel Stronger on GLP-1s

Coffee intolerance on Ozempic: What’s happening

Read More

Ozempic and Alcohol Intolerance: Why Drinks Hit Harder and Safer Guidelines

Ozempic alcohol intolerance: Why drinks feel stronger

Read More

Ozempic and Food Aversion: Why Certain Foods Suddenly Feel “Impossible”

Ozempic appetite changes: Food aversion explained

Read More